Imaging of angiogenesis using Cadence contrast pulse sequencing and targeted contrast agents.

OBJECTIVES Low-power multipulse contrast ultrasound imaging provides a promising tool to quantify angiogenesis noninvasively when used with contrast agents targeted to vascular markers expressed by the angiogenic endothelium. Targeted ultrasound contrast agents, with a diameter on the order of micrometers, cannot extravasate and therefore are targeted solely to receptors expressed by the vascular endothelium. The aim of this study was to evaluate the potential of a low-power multipulse imaging sequence, Cadence(TM) contrast pulse sequencing (CPS), combined with targeted contrast agents to quantify angiogenesis. MATERIAL AND METHODS Targeted microbubbles were prepared by conjugating echistatin via biotin-avidin linkage to the surface of a phospholipid microbubble shell. The density of echistatin present on the shell was confirmed with flow-cytometry and quantified by total fluorescence. The binding of targeted microbubbles was evaluated in vitro by quantifying the adherence of targeted microbubbles to rat aortic endothelial cells, compared with control (nontargeted) microbubbles. The circulation time and adherence of targeted microbubbles was evaluated in vivo in a Matrigel model in rats and compared with control microbubbles using CPS in addition to a destructive ultrasound pulse. RESULTS Using only the low-power CPS pulse, the echo intensity produced in the neovasculature of the Matrigel pellet was significantly greater with targeted microbubbles than with the control contrast agent (p < 0.001). Combining CPS with the destructive pulse, the processed image was significantly different in intensity (p < 0.001) and spatial extent between targeted and control agents (p < 0.001). When the morphology of the histological sample and ultrasound image correlated, the microvessel density count and the percentage of the circular area enhanced by ultrasound were correlated (p < 0.05). CONCLUSION Low-power multipulse imaging in combination with targeted echistatin-bearing microbubbles facilitated a noninvasive, quantitative evaluation of early angiogenesis during real-time imaging. The addition of high-intensity destructive pulses facilitated estimation of the spatial extent of angiogenesis.

[1]  Samuel A Wickline,et al.  Targeted ultrasonic contrast agents for molecular imaging and therapy. , 2001, Current problems in cardiology.

[2]  Jonathan R Lindner,et al.  Molecular imaging with contrast ultrasound and targeted microbubbles , 2004, Journal of Nuclear Cardiology.

[3]  Olivier Lucidarme,et al.  Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model. , 2006, Radiology.

[4]  P. Sevelda,et al.  Color-coded and spectral Doppler flow in breast carcinomas – Relationship with the tumor microvasculature , 2004, Breast Cancer Research and Treatment.

[5]  J. Calvete,et al.  Structural Requirements of Echistatin for the Recognition of αvβ3 and α5β1Integrins* , 1999, The Journal of Biological Chemistry.

[6]  G. Alghisi,et al.  Vascular integrins in tumor angiogenesis: mediators and therapeutic targets. , 2006, Endothelium : journal of endothelial cell research.

[7]  A R Padhani,et al.  Challenges for imaging angiogenesis. , 2001, The British journal of radiology.

[8]  Jonathan R. Lindner,et al.  Noninvasive Assessment of Angiogenesis by Ultrasound and Microbubbles Targeted to &agr;v-Integrins , 2003, Circulation.

[9]  Alexander L. Klibanov,et al.  Microbubble Contrast Agents: Targeted Ultrasound Imaging and Ultrasound-Assisted Drug-Delivery Applications , 2006, Investigative radiology.

[10]  M. Bednarski,et al.  Molecular Imaging Applications in Nanomedicine , 2004, Biomedical microdevices.

[11]  E. Maxwell,et al.  Biochemical Characterization of the Binding of Echistatin to Integrin αvβ3 Receptor , 1997 .

[12]  N. Weidner,et al.  Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.

[13]  James H Thrall,et al.  Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.

[14]  Paul A Dayton,et al.  Lateral phase separation in lipid-coated microbubbles. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[15]  P. Brooks,et al.  Role of integrins in angiogenesis. , 1996, European journal of cancer.

[16]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[17]  K W Ferrara,et al.  Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. , 2000, Academic radiology.

[18]  Jiri Sklenar,et al.  Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. , 2003, Circulation.

[19]  D. Noh,et al.  Identification of Angiogenesis in Primary Breast Carcinoma According to the Image Analysis , 2002, Breast Cancer Research and Treatment.

[20]  A. Harris,et al.  Histological quantitation of tumour angiogenesis , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[21]  Paul A. Dayton,et al.  Radiation-Force Assisted Targeting Facilitates Ultrasonic Molecular Imaging , 2004 .

[22]  R V Shohet,et al.  Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles , 2005, Gene Therapy.

[23]  E. Maxwell,et al.  Biochemical characterization of the binding of echistatin to integrin alphavbeta3 receptor. , 1997, The Journal of pharmacology and experimental therapeutics.

[24]  K. Nicolay,et al.  Early in vivo assessment of angiostatic therapy efficacy by molecular MRI , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  M. Bednarski,et al.  Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.

[26]  P. Phillips,et al.  Contrast pulse sequences (CPS): imaging nonlinear microbubbles , 2001, 2001 IEEE Ultrasonics Symposium. Proceedings. An International Symposium (Cat. No.01CH37263).

[27]  N. Green,et al.  A preliminary crystallographic investigation of avidin. , 1970, The Biochemical journal.

[28]  N. Weidner,et al.  Tumor angiogenesis: review of current applications in tumor prognostication. , 1993, Seminars in diagnostic pathology.

[29]  S. Delorme,et al.  Fibroadenomas: computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology. , 2001, Ultrasound in medicine & biology.

[30]  S. Kaul,et al.  Assessment of Endogenous and Therapeutic Arteriogenesis by Contrast Ultrasound Molecular Imaging of Integrin Expression , 2005, Circulation.

[31]  Michael Simons,et al.  Arteriogenesis : Noninvasive Quantification with Multi – Detector Row CT Angiography and Three-dimensional Volume Rendering in Rodents 1 , 2006 .

[32]  J. Lindner,et al.  Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.

[33]  James M Provenzale,et al.  Imaging of angiogenesis: clinical techniques and novel imaging methods. , 2007, AJR. American journal of roentgenology.

[34]  S. Kaul,et al.  Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. , 2000, Circulation.

[35]  S. Kaul,et al.  Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. , 2000, Circulation.

[36]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[37]  Jonathan R. Lindner,et al.  Imaging Tumor Angiogenesis With Contrast Ultrasound and Microbubbles Targeted to &agr;v&bgr;3 , 2003 .

[38]  William R Wagner,et al.  Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine. , 2005, Cancer research.

[39]  Men-Tzung Lo,et al.  Factor analysis in both spatial and temporal domains of color blooming artifacts in ultrasound investigations utilizing contrast agents. , 2004, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

[40]  Eric Tom,et al.  Myocardial Ischemic Memory Imaging With Molecular Echocardiography , 2007, Circulation.